Andere Sprachen West Pharmaceutical Services, Inc.

Aktien

864330

US9553061055

WST

Markt geschlossen - Nyse Andere Börsenplätze 22:00:01 03.05.2024			% 5 Tage	% 1. Jan.
365 ^USD	-0,93 %		+1,27 %	+3,66 %

26.04.	Bernard Birkett hat nicht länger die Position des Principal Operating Officer von West Pharmaceutical Services, Inc.	CI
26.04.	WEST PHARMACEUTICAL SERVICES, INC. : UBS gibt neutrale Bewertung ab	ZM

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

West to Participate in Upcoming Investor Conference	30.04.
Declaration of Voting Results of the West Pharmaceutical Services Inc	26.04.
Bernard Birkett No Longer Have Principal Operating Officer Position of West Pharmaceutical Services, Inc	26.04.
Health Care Drops Amid Mixed Earnings -- Health Care Roundup	25.04.
Tranche Update on West Pharmaceutical Services, Inc.'s Equity Buyback Plan announced on February 16, 2023.	25.04.
West Pharmaceutical's Q1 Adjusted Earnings, Net Sales Fall; 2024 Adjusted EPS Outlook Raised	25.04.
Earnings Flash (WST) WEST PHARMACEUTICAL SERVICES Reports Q1 Revenue $695.4M, vs. Street Est of $671.7M	25.04.
Earnings Flash (WST) WEST PHARMACEUTICAL SERVICES Posts Q1 EPS $1.56, vs. Street Est of $1.29	25.04.
West Pharmaceutical: Q1 Earnings Snapshot	25.04.
West Announces First-Quarter 2024 Results and Declares Third-Quarter 2024 Dividend	25.04.
West Pharmaceutical Services, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	25.04.
West Pharmaceutical Services, Inc. Reaffirms Earnings Guidance for the Full Year 2024	25.04.
West Pharmaceutical Services, Inc. Announces Third Quarter 2024 Dividend, Payable on August 7, 2024	25.04.
West to Host First-Quarter 2024 Conference Call	11.04.
Weight-loss drug deals to drive around 4% of Gerresheimer yearly growth, CEO says	29.03.
West Pharmaceutical Services : 2024 Proxy	14.03.
Pacific Edge's Chair to Retire; Shares Fall 3%	14.03.
West Pharmaceutical Services Inc Files a Definitive Proxy Statement	13.03.
West Pharmaceutical Services Insider Sold Shares Worth $292,436, According to a Recent SEC Filing	12.03.
Accenture : acquisition de la société australienne The Lumery	04.03.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen West Pharmaceutical Services, Inc.

Aktien

864330

US9553061055

WST

Andere Sprachen

Filter